These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19230723)

  • 21. Enhanced FTY720-mediated lymphocyte homing requires G alpha i signaling and depends on beta 2 and beta 7 integrin.
    Pabst O; Herbrand H; Willenzon S; Worbs T; Schippers A; Müller W; Bernhardt G; Förster R
    J Immunol; 2006 Feb; 176(3):1474-80. PubMed ID: 16424175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
    Kihara A; Igarashi Y
    Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.
    Cyster JG; Schwab SR
    Annu Rev Immunol; 2012; 30():69-94. PubMed ID: 22149932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.
    Lan YY; De Creus A; Colvin BL; Abe M; Brinkmann V; Coates PT; Thomson AW
    Am J Transplant; 2005 Nov; 5(11):2649-59. PubMed ID: 16212624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3.
    Maeda Y; Matsuyuki H; Shimano K; Kataoka H; Sugahara K; Chiba K
    J Immunol; 2007 Mar; 178(6):3437-46. PubMed ID: 17339438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes.
    Honig SM; Fu S; Mao X; Yopp A; Gunn MD; Randolph GJ; Bromberg JS
    J Clin Invest; 2003 Mar; 111(5):627-37. PubMed ID: 12618517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow.
    Jenne CN; Enders A; Rivera R; Watson SR; Bankovich AJ; Pereira JP; Xu Y; Roots CM; Beilke JN; Banerjee A; Reiner SL; Miller SA; Weinmann AS; Goodnow CC; Lanier LL; Cyster JG; Chun J
    J Exp Med; 2009 Oct; 206(11):2469-81. PubMed ID: 19808259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine 1-phosphate receptors regulate chemokine-driven transendothelial migration of lymph node but not splenic T cells.
    Yopp AC; Ochando JC; Mao M; Ledgerwood L; Ding Y; Bromberg JS
    J Immunol; 2005 Sep; 175(5):2913-24. PubMed ID: 16116177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.
    Ledgerwood LG; Lal G; Zhang N; Garin A; Esses SJ; Ginhoux F; Merad M; Peche H; Lira SA; Ding Y; Yang Y; He X; Schuchman EH; Allende ML; Ochando JC; Bromberg JS
    Nat Immunol; 2008 Jan; 9(1):42-53. PubMed ID: 18037890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.
    Brinkmann V; Cyster JG; Hla T
    Am J Transplant; 2004 Jul; 4(7):1019-25. PubMed ID: 15196057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.
    Mandala S; Hajdu R; Bergstrom J; Quackenbush E; Xie J; Milligan J; Thornton R; Shei GJ; Card D; Keohane C; Rosenbach M; Hale J; Lynch CL; Rupprecht K; Parsons W; Rosen H
    Science; 2002 Apr; 296(5566):346-9. PubMed ID: 11923495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.
    Xie JH; Nomura N; Koprak SL; Quackenbush EJ; Forrest MJ; Rosen H
    J Immunol; 2003 Apr; 170(7):3662-70. PubMed ID: 12646631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FTY720 regulates bone marrow egress of eosinophils and modulates late-phase skin reaction in mice.
    Sugita K; Kabashima K; Sakabe J; Yoshiki R; Tanizaki H; Tokura Y
    Am J Pathol; 2010 Oct; 177(4):1881-7. PubMed ID: 20802177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia.
    Sensken SC; Nagarajan M; Bode C; Gräler MH
    J Immunol; 2011 Mar; 186(6):3432-40. PubMed ID: 21289303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine 1-phosphate receptor agonist FTY720-phosphate causes marginal zone B cell displacement.
    Vora KA; Nichols E; Porter G; Cui Y; Keohane CA; Hajdu R; Hale J; Neway W; Zaller D; Mandala S
    J Leukoc Biol; 2005 Aug; 78(2):471-80. PubMed ID: 15894589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
    Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
    Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis.
    Zhang ZY; Zhang Z; Schluesener HJ
    Neuropathol Appl Neurobiol; 2009 Oct; 35(5):487-95. PubMed ID: 19207263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis.
    Chun J; Hartung HP
    Clin Neuropharmacol; 2010; 33(2):91-101. PubMed ID: 20061941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.